GSK Plc (GSK)
53.78
+0.39
(+0.73%)
USD |
NYSE |
Mar 16, 16:00
53.78
0.00 (0.00%)
After-Hours: 20:00
GSK Market Cap : 107.73B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 297.86B |
| Biodexa Pharmaceuticals Plc | 0.6690M |
| Mereo BioPharma Group Plc | 63.90M |
| BioNTech SE | 22.74B |
| Rapt Therapeutics, Inc. (DELISTED) | 959.52M |
Market Cap Related Metrics
| PE Ratio | 14.68 |
| PS Ratio | 2.563 |
| PEG Ratio | 0.1116 |
| Price to Book Value | 4.891 |
| Price to Free Cash Flow | 19.34 |
| Price | 53.78 |
| Earnings Yield | 6.81% |
| PEGY Ratio | 0.1088 |
| Operating PE Ratio | 11.35 |
| Normalized PE Ratio | 13.60 |